AR010585A1 - Compuesto derivado de oxometileno, proceso para su preparacion, composicion farmaceutica que lo contiene y su uso para la fabricacion de agentesterapeuticos - Google Patents
Compuesto derivado de oxometileno, proceso para su preparacion, composicion farmaceutica que lo contiene y su uso para la fabricacion de agentesterapeuticosInfo
- Publication number
- AR010585A1 AR010585A1 ARP970105280A ARP970105280A AR010585A1 AR 010585 A1 AR010585 A1 AR 010585A1 AR P970105280 A ARP970105280 A AR P970105280A AR P970105280 A ARP970105280 A AR P970105280A AR 010585 A1 AR010585 A1 AR 010585A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- oxomethylene
- manufacture
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Un compuesto de la formula (I) y las sales y ésteres metabolicamente lábiles del mismo, en donde R es un grupo arilo o heteroarilo opcionalmentesustituido;A es una cadena de propileno o A es una cadena de 3 miembros,uno de los cuales seselec ciona a partir de un átomo de oxígeno de azufre o el grupoNH o un derivado sustituido del mismo y los otros dos miembros son grupos metileno, que tiene actividad antibacteriana, procesos para su preparacion ya su uso en medicina. Loscompuestos tienen un perfil particularmente ventajoso de actividad antibacteriana, que incluyen buena actividad contramicroorganismos gram positivos tal como el Staphylococcus aureus, resistente a la meticilina (MRSA) y elStaphylococcus epidermid is resistente a lameticilina (MRSE).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9623684.9A GB9623684D0 (en) | 1996-11-14 | 1996-11-14 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR010585A1 true AR010585A1 (es) | 2000-06-28 |
Family
ID=10802915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970105280A AR010585A1 (es) | 1996-11-14 | 1997-11-12 | Compuesto derivado de oxometileno, proceso para su preparacion, composicion farmaceutica que lo contiene y su uso para la fabricacion de agentesterapeuticos |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0937078B1 (es) |
| JP (1) | JP2001503765A (es) |
| KR (1) | KR20000053258A (es) |
| AR (1) | AR010585A1 (es) |
| AT (1) | ATE232532T1 (es) |
| AU (1) | AU727328B2 (es) |
| BR (1) | BR9713982A (es) |
| CA (1) | CA2271732A1 (es) |
| DE (1) | DE69719054T2 (es) |
| ES (1) | ES2191207T3 (es) |
| GB (1) | GB9623684D0 (es) |
| HR (1) | HRP970611A2 (es) |
| PE (1) | PE14099A1 (es) |
| TR (1) | TR199901705T2 (es) |
| TW (1) | TW438802B (es) |
| WO (1) | WO1998021210A1 (es) |
| ZA (1) | ZA9710207B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1055683A4 (en) | 1998-02-17 | 2007-07-25 | Nippon Kayaku Kk | NEW ACETAMIDE DERIVATIVE AND USE THEREOF |
| US7601847B2 (en) | 2004-10-26 | 2009-10-13 | Wyeth | Preparation and purification of 4-(indazol-3-yl)phenols |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ285778B6 (cs) * | 1989-09-08 | 1999-11-17 | Glaxo S.P.A. | Kyselina 10-(1-hydroxyethyl)-11-oxo-1-azatricyklo/7,2,0,03,8/-undec-2en-2-karboxylová a její deriváty, způsob jejich výroby, použití pro výrobu farmaceutických prostředků a farmaceutické prostředky s jejich obsahem |
| AU636913B2 (en) * | 1989-10-11 | 1993-05-13 | Takeda Chemical Industries Ltd. | Tricyclic carbapenem compounds |
| EP0507313A1 (en) * | 1991-04-05 | 1992-10-07 | Takeda Chemical Industries, Ltd. | Polycyclic carbapenem compounds, their production and use |
| JPH06166688A (ja) * | 1992-10-02 | 1994-06-14 | Takeda Chem Ind Ltd | カルバペネム化合物、その製造法および抗菌組成物 |
| JPH08245628A (ja) * | 1995-01-12 | 1996-09-24 | Takeda Chem Ind Ltd | カルバペネム化合物、その製造法および剤 |
-
1996
- 1996-11-14 GB GBGB9623684.9A patent/GB9623684D0/en active Pending
-
1997
- 1997-11-12 ZA ZA9710207A patent/ZA9710207B/xx unknown
- 1997-11-12 AU AU54815/98A patent/AU727328B2/en not_active Ceased
- 1997-11-12 EP EP97951174A patent/EP0937078B1/en not_active Expired - Lifetime
- 1997-11-12 CA CA002271732A patent/CA2271732A1/en not_active Abandoned
- 1997-11-12 TR TR1999/01705T patent/TR199901705T2/xx unknown
- 1997-11-12 BR BR9713982-3A patent/BR9713982A/pt not_active IP Right Cessation
- 1997-11-12 JP JP52217698A patent/JP2001503765A/ja not_active Ceased
- 1997-11-12 WO PCT/EP1997/006299 patent/WO1998021210A1/en active IP Right Grant
- 1997-11-12 AR ARP970105280A patent/AR010585A1/es unknown
- 1997-11-12 ES ES97951174T patent/ES2191207T3/es not_active Expired - Lifetime
- 1997-11-12 AT AT97951174T patent/ATE232532T1/de not_active IP Right Cessation
- 1997-11-12 KR KR1019990704237A patent/KR20000053258A/ko not_active Application Discontinuation
- 1997-11-12 PE PE1997001012A patent/PE14099A1/es not_active Application Discontinuation
- 1997-11-12 DE DE69719054T patent/DE69719054T2/de not_active Expired - Lifetime
- 1997-11-13 HR HR9623684.9A patent/HRP970611A2/hr not_active Application Discontinuation
- 1997-12-03 TW TW086118192A patent/TW438802B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001503765A (ja) | 2001-03-21 |
| GB9623684D0 (en) | 1997-01-08 |
| KR20000053258A (ko) | 2000-08-25 |
| HRP970611A2 (en) | 1998-10-31 |
| BR9713982A (pt) | 2000-05-02 |
| EP0937078B1 (en) | 2003-02-12 |
| AU5481598A (en) | 1998-06-03 |
| CA2271732A1 (en) | 1998-05-22 |
| EP0937078A1 (en) | 1999-08-25 |
| ES2191207T3 (es) | 2003-09-01 |
| WO1998021210A1 (en) | 1998-05-22 |
| AU727328B2 (en) | 2000-12-07 |
| TW438802B (en) | 2001-06-07 |
| DE69719054T2 (de) | 2003-11-27 |
| TR199901705T2 (xx) | 1999-12-21 |
| ZA9710207B (en) | 1999-05-12 |
| DE69719054D1 (de) | 2003-03-20 |
| PE14099A1 (es) | 1999-03-19 |
| ATE232532T1 (de) | 2003-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200400944A1 (ru) | Замещенные производные тетрациклина, фармацевтическая композиция и способ лечения субъекта с их использованием | |
| MX2020007944A (es) | Nanocomplejos similares a los lípidos y sus usos. | |
| RU94029662A (ru) | Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения | |
| PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
| BRPI0519384A2 (pt) | misturas sinergÍsticas com efeito inseticida e fungicida | |
| ATE342054T1 (de) | Verfahren und zusammansetzung zur behandlung von krebs | |
| EA200501098A1 (ru) | Антибактериальные агенты | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| HRP20060276B1 (hr) | 6-0-supstituirani ketolidi antibakterijskog djelovanja | |
| CR8482A (es) | Nuevos derivados de quinolina | |
| UY27882A1 (es) | Compuestos quimicos | |
| ECSP078052A (es) | Nuevos derivados de la 2-azetidinona como inhibidores de la absorción del colesterol para el tratamiento de condiciones hiperlipidémicas | |
| ECSP078051A (es) | Nuevos derivados de la 2-azetidinona como inhibidores de la absorción del colesterol para el tratamiento de condiciones hiperlipidémicas | |
| BRPI0413876A (pt) | tienopiridin-fenilacetamidas e seus derivados úteis como agentes antiangiogênicos | |
| NO20071314L (no) | Peptidiske vasopressinreseptoragonister | |
| DE60214179D1 (de) | IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN | |
| UY28695A1 (es) | Derivados de difenilazetidona | |
| CY1117501T1 (el) | Αγωγη νοσηματων τα οποια σχετιζονται με τη χρηση αντιβιοτικων | |
| BRPI0406717A (pt) | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção | |
| ECSP045469A (es) | El uso de cianopirrolidinas sustituidas y preparaciones de combinacion que las contienen para tratar hiperlipidemia y enfermedades asociadas | |
| BR9812148A (pt) | Derivados de eritromicina 6,9-ligados em ponte | |
| UY27685A1 (es) | Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso | |
| AR007021A1 (es) | Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos | |
| AR017904A1 (es) | Mezclas fungicidas y procedimentos para controlar hongos nocivos que las emplean. | |
| BR0311136A (pt) | composto ou um sal, enanciÈmero, diaestereÈmero ou éster hidrolisável in vivo ou mistura dos mesmos farmaceuticamente aceitável, composição, e, método para inibir a atividade de fator letal (lf) liberado de bactérias em um mamìfero |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |